simvastatin has been researched along with ryanodine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Alvarez de Sotomayor, M; Andriantsitohaina, R | 1 |
Hohenegger, M; Sacher, J; Szegedi, C; Weigl, L; Werner, M | 1 |
Cardaba, CM; Mueller, A | 1 |
Lindsay, C; Musgaard, M; Russell, AJ; Sitsapesan, R | 1 |
4 other study(ies) available for simvastatin and ryanodine
Article | Year |
---|---|
Simvastatin and Ca(2+) signaling in endothelial cells: involvement of rho protein.
Topics: Aminobenzoates; Animals; Aorta; Botulinum Toxins; Bradykinin; Calcium; Calcium Signaling; Catalase; Cattle; Cells, Cultured; Chlorobenzoates; Cinnamates; Endothelium, Vascular; Free Radical Scavengers; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; ortho-Aminobenzoates; Phospholipases A; rho GTP-Binding Proteins; Ryanodine; Simvastatin; Superoxide Dismutase; Superoxides; Thapsigargin | 2001 |
Delineation of myotoxicity induced by 3-hydroxy-3-methylglutaryl CoA reductase inhibitors in human skeletal muscle cells.
Topics: Apoptosis; Calcium; Calpain; Cells, Cultured; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mitochondria; Muscle Cells; Muscle, Skeletal; Ryanodine; Signal Transduction; Simvastatin | 2005 |
Distinct modes of molecular regulation of CCL3 induced calcium flux in monocytic cells.
Topics: Animals; Anticholesteremic Agents; beta-Cyclodextrins; Calcium; Caveolae; Cell Line; Cell Membrane; Chemokine CCL3; CHO Cells; Cholesterol; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; GTP-Binding Proteins; Humans; Inositol 1,4,5-Trisphosphate Receptors; Kidney; Lovastatin; Membrane Microdomains; Monocytes; Pertussis Toxin; Receptors, CCR5; Receptors, G-Protein-Coupled; Ryanodine; Ryanodine Receptor Calcium Release Channel; Signal Transduction; Simvastatin; Thapsigargin; Time Factors | 2009 |
Statin activation of skeletal ryanodine receptors (RyR1) is a class effect but separable from HMG-CoA reductase inhibition.
Topics: Acyl Coenzyme A; Animals; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Muscle, Skeletal; Muscular Diseases; Rabbits; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sheep; Simvastatin | 2022 |